| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 858.10M | 1.67B | 1.03B | -720.40M | 1.50B | 634.43M |
| Gross Profit | 353.00M | 1.67B | 1.03B | -1.29B | 1.49B | 634.43M |
| EBITDA | 13.80M | 49.70M | 31.40M | -48.40M | 42.19M | 52.04M |
| Net Income | -7.90M | 3.90M | 18.70M | -33.70M | 27.29M | 21.19M |
Balance Sheet | ||||||
| Total Assets | 13.51B | 12.76B | 12.13B | 11.14B | 9.42B | 8.86B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 138.00M | 146.00M | 204.60M | 70.09M | 105.35M |
| Total Debt | 203.80M | 206.20M | 209.30M | 213.23M | 49.46M | 71.44M |
| Total Liabilities | 13.22B | 12.44B | 11.77B | 10.81B | 8.96B | 8.37B |
| Stockholders Equity | 293.30M | 314.40M | 359.90M | 333.12M | 458.17M | 487.07M |
Cash Flow | ||||||
| Free Cash Flow | 44.70M | 37.80M | -35.70M | -80.43M | 20.69M | 49.34M |
| Operating Cash Flow | 45.90M | 38.60M | -34.90M | -76.92M | 24.32M | 50.20M |
| Investing Cash Flow | 4.60M | 5.00M | 29.50M | 52.05M | -3.64M | 1.88M |
| Financing Cash Flow | -33.90M | -49.70M | -49.80M | 121.30M | -52.25M | -61.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £27.21B | 10.72 | 20.51% | 1.67% | 37.94% | 291.37% | |
68 Neutral | $623.57M | -6.26 | -8.73% | ― | -15.79% | -212.00% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | £378.95M | -9.95 | -76.14% | ― | -35.05% | 74.73% | |
62 Neutral | £640.35M | -61.12 | -2.53% | 8.46% | -48.03% | -289.17% | |
58 Neutral | £6.73B | -10.62 | -49.24% | 8.00% | -34.62% | -19.20% | |
51 Neutral | £62.61M | 34.70 | 9.65% | 9.78% | -52.34% | -65.35% |
Chesnara plc has announced that its Group CEO, Steve Murray, and Group CFO, Tom Howard, have acquired additional ordinary shares in the company through a dividend reinvestment plan. This acquisition reflects confidence in the company’s ongoing strategy and financial health, as Chesnara continues to focus on efficient policy management and expansion through new business and acquisitions.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced that its issued share capital consists of 230,758,230 ordinary shares, each carrying one voting right, which shareholders can use to determine their interest in the company. This announcement aligns with Chesnara’s commitment to transparency and may impact stakeholders by clarifying their voting rights and interests in the company.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £287.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara reported strong financial performance in its 2025 interim results, with a 26% increase in cash generation to £37m and a 3% rise in the interim dividend. The company announced a transformational acquisition of HSBC Life (UK), expected to significantly boost cash generation and support long-term growth. Chesnara’s strategic progress includes a successful rights issue and admission to the FTSE 250 Index, positioning the company for further expansion and shareholder value enhancement.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £290.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc is set to announce its interim results for the first half of 2025 on August 28, with a presentation for analysts and investors scheduled for the same day. This announcement is part of Chesnara’s ongoing strategy to maintain transparency and engagement with stakeholders, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced the successful pricing of £150 million Fixed Rate Reset Perpetual Restricted Tier 1 Contingent Convertible Notes, with proceeds intended for general corporate purposes, including investments and acquisitions. The issuance supports Chesnara’s financial flexibility for future acquisitions, following its recent £140 million Rights Issue for the HSBC Life (UK) transaction, and reflects a positive outlook for mergers and acquisitions.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.